☆ 4.7 Article

I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs

BIOMEDICINE & PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models

Mihaly Varadi et al.

Summary: AlphaFold DB is an openly accessible database with high-accuracy protein-structure predictions, powered by DeepMind's AlphaFold v2.0. It provides programmatic access to a vast number of predicted structures and is expanding to cover more sequences.

NUCLEIC ACIDS RESEARCH (2022)

添加到收藏夹

Article Oncology

Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines

Maciej Sobczak et al.

Summary: In this research, the CoREST complex is identified as a key factor that controls the expression of ABC transporters in cisplatin-treated cancer cells, preventing multidrug resistance. The CoREST complex occupancy at gene promoters suppresses the EP300-dependent increase in ABCC transcription induced by cisplatin and gene overexpression in cisplatin-resistant phenotypes. The EP300-mediated activation of ABCC10 in response to cisplatin is only possible in the presence of p53.

CANCERS (2022)

添加到收藏夹

Review Oncology

Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers

Hui-Yan Sun et al.

Summary: This review discusses the role of BET proteins in gastrointestinal cancers and highlights the therapeutic potential of targeting BET proteins for the treatment of these cancers.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

添加到收藏夹

Article Biochemical Research Methods

FitDock: protein-ligand docking by template fitting

Xiaocong Yang et al.

Summary: Protein-ligand docking is crucial in drug design and bioinformatics. FitDock, a new method, has shown significant improvement in docking success rate and speed compared to popular methods, especially when template structures are available.

BRIEFINGS IN BIOINFORMATICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

CB-Dock2: improved protein ligand blind docking by integrating cavity detection, docking and homologous template fitting

Yang Liu et al.

Summary: Protein-ligand blind docking is a powerful method for exploring the binding sites of receptors and ligand binding poses. In this study, we improved the docking method by combining CB-Dock with a template-based docking engine, resulting in the development of CB-Dock2. The updated docking server demonstrated better accuracy in binding site identification and binding pose prediction, outperforming other blind docking tools.

NUCLEIC ACIDS RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer

Thiago S. Lima et al.

Summary: Itraconazole can re-sensitize docetaxel-resistant prostate and breast cancer cells by binding to ABC transporter protein ABCB1, inhibiting the transport of docetaxel.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Oncology

Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer

Miwako Omori et al.

Summary: This study identified key factors in the chemoresistance of SCLC, including drug efflux proteins ABCB1 and ABCG2. Inhibiting these proteins can restore drug sensitivity and promote apoptotic activity in SCLC cells. ABC transporter inhibitors may be a promising therapeutic strategy for overcoming resistance to topoisomerase inhibitors in SCLC patients.

THORACIC CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

IncreasedABCC2expression predicts cisplatin resistance in non-small cell lung cancer

Yun Chen et al.

Summary: Long-term use of platinum-based drugs can lead to strong drug resistance in NSCLC. Increasing drug dosage is not effective and may cause complications. High levels of drug resistance in tumors are usually mediated by multidrug resistance-related genes. In this study, ABCC2 was found to be upregulated in cisplatin-resistant NSCLC cells and knockdown of ABCC2 reversed cisplatin resistance, suggesting it could be a potential therapeutic strategy for overcoming drug resistance in NSCLC patients.

CELL BIOCHEMISTRY AND FUNCTION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells

Mehmet Bugrahan Duz et al.

Summary: The study revealed that expressions of ABCB1 and ABCG2 gradually increased and reached a maximum level in Taxol 8x cells. Meanwhile, KLF4 expression significantly elevated as parental cells acquired resistance to the lowest dose of paclitaxel and increased stepwise. The levels of other tested ATP-binding cassette transporters and stem cell markers also increased at different stages of paclitaxel resistance acquisition.

MOLECULAR BIOLOGY REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation

Yixuan Zhou et al.

Summary: The study found that lysine acetyl transferases p300/CREB binding protein (CBP) control MHC-I antigen processing and presentation (AgPP) in human cancers, and that chemotherapeutic drugs like oxaliplatin and mitoxantrone can enhance tumor sensitivity to PD-(L)1 inhibitors by up-regulating MHC-I AgPP.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Review Oncology

Achieving clinical success with BET inhibitors as anti-cancer agents

Tatiana Shorstova et al.

Summary: Transcriptional upregulation of oncogenes drives tumor progression, and targeting BET proteins with inhibitors has shown promise in suppressing oncogenic networks in tumors. Understanding the biology of BET proteins, designing better BET inhibitors, and incorporating BET inhibitors into combination therapies can enhance their efficacy in clinical settings.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance

Huan Xiao et al.

Summary: This review summarizes the recent advances in important cancer-related ABC transporters, focusing on their physiological functions, structures, and the development of new compounds as ABC transporter inhibitors, highlighting the potential use of modulators to enhance the therapeutic efficacy of chemotherapy drugs.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Macrophage Polarization States in the Tumor Microenvironment

Ava J. Boutilier et al.

Summary: The M1/M2 macrophage paradigm is crucial in tumor progression, where M1 macrophages have anti-tumor effects and M2 macrophages contribute to tumor development through various mechanisms. The tumor microenvironment plays a role in influencing macrophage polarization and activation, which is essential for understanding the pro-tumor effects of tumor-associated macrophages.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2

Julia Kowal et al.

Summary: In this study, three cryo-EM structures of human ABCG2 bound to anticancer drugs tariquidar, topotecan, and mitoxantrone were presented, revealing the binding pocket details and functional importance of key residues. Mutagenesis experiments and 3D variability analysis provided further insights into the mechanisms by which ABCG2 distinguishes between inhibitors and substrates.

JOURNAL OF MOLECULAR BIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Highly accurate protein structure prediction for the human proteome

Kathryn Tunyasuvunakool et al.

Summary: Using the AlphaFold method, the structural coverage of the proteome has been significantly expanded, covering 98.5% of human proteins with 58% of residues having confident predictions and 36% having very high confidence. Introducing new metrics to interpret the dataset and identify disordered regions, this study aims to provide high-quality predictions for generating biological hypotheses.

NATURE (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?

Dirk Theile et al.

Summary: Acquired multidrug resistance in tumor diseases is often linked to overexpression of ATP-binding cassette transporters like P-glycoprotein. This overexpression can be experimentally achieved by exposure to cytotoxic drugs, with two opposite mechanisms potentially explaining this phenomenon.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells

Wang Yin et al.

Summary: Inhibiting MDR1 or ABCG2 was found to increase the sensitivity of liver cancer stem cells to doxorubicin, leading to elevated intracellular concentration of the drug and increased apoptosis. This approach effectively reversed chemoresistance in liver cancer stem cells, demonstrating a promising strategy for enhancing the therapeutic efficacy of doxorubicin.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

CBP/p300 Bromodomain Inhibitor-I-CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs

Magdalena Strachowska et al.

Summary: This study investigated the CBP/p300 bromodomain inhibitor I-CBP112, which can repress multidrug-resistance genes, enhance drug accumulation inside cells, and significantly potentiate drug effects. It was found that I-CBP112 decreased the expression of certain ABC transporters in breast, lung, and hepatic cancer cell lines, leading to increased sensitivity to a wide range of chemotherapeutics. This compound shows promise as a potent anti-multidrug-resistance agent in various cancer types.

CANCERS (2021)

添加到收藏夹

Article Oncology

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer

Tina Bagratuni et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Diurnal expression of MRP4 in bone marrow cells underlies the dosing-time dependent changes in the oxaliplatin-induced myelotoxicity

Mizuki Kato et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Review Oncology

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

Jiun- Lai et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs

Aleksandra Luginina et al.

SCIENCE ADVANCES (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

EP300-HDAC1-SWI/SNF functional unit defines transcription of some DNA repair enzymes during differentiation of human macrophages

Julita Pietrzak et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)

添加到收藏夹

Article Oncology

MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer

S. G. Creemers et al.

ENDOCRINE-RELATED CANCER (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin

Liang Yan et al.

MOLECULAR PHARMACOLOGY (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Synthesis of a Fluorescent Analogue of Paclitaxel That Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein

Molly M. Lee et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112

Beth E. Zucconi et al.

BIOCHEMISTRY (2016)

添加到收藏夹

Article Oncology

Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells

Hisashi Masuyama et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy

Sarah Picaud et al.

CANCER RESEARCH (2015)

添加到收藏夹

Article Oncology

JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer

Haifeng Qiu et al.

ONCOTARGET (2015)

添加到收藏夹

Article Oncology

Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

Feifei Xu et al.

CANCER CELL INTERNATIONAL (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Analysis of the RelA:CBP/p300 Interaction Reveals Its Involvement in NF-κB-Driven Transcription

Sulakshana P. Mukherjee et al.

PLOS BIOLOGY (2013)

添加到收藏夹

Article Pharmacology & Pharmacy

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

J. A. Sprowl et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

The controversial role of ABC transporters in clinical oncology

Akina Tamaki et al.

ESSAYS IN BIOCHEMISTRY: ABC TRANSPORTERS (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Selective inhibition of BET bromodomains

Panagis Filippakopoulos et al.

NATURE (2010)

添加到收藏夹

Article Oncology

Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes

A. M. Calcagno et al.

BRITISH JOURNAL OF CANCER (2008)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Targeting multidrug resistance in cancer

G Szakács et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

添加到收藏夹

Article Oncology

The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites

S Pratt et al.

MOLECULAR CANCER THERAPEUTICS (2005)

添加到收藏夹

Article Oncology

Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure

BQ Guo et al.

BREAST CANCER RESEARCH AND TREATMENT (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.